15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 6 firms covering Carter’s Inc, 1 rate it Buy or better, 3 sit at Hold, and 2 rate it Sell or worse, a hold consensus. Targets span $26.00 to $50.00, a moderate spread. The average target of $37.60 sits 5% below the current $39.44. Sentiment has drifted a little more constructive lately, with Sell ratings easing from 3 to 2 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.89 next quarter toward $3.65 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS6 ratings
Hold
Strong Buy00%
Buy117%
Hold350%
Sell233%
Strong Sell00%
Based on 6 analysts giving stock ratings to Carter’s Inc.
As of Jul, 1 of 6 firms rate CRI a Buy (3 Hold, 2 Sell), the standing distribution of every covering firm's most recent active call.
CRI EPS & revenue forecast
EPS · NEXT QUARTER
$0.89
Range $0.70 – $1.07 · 6 analysts · +20% YoY
Next period, 6 analysts expect Carter’s Inc to earn $0.89 a share (range $0.70 – $1.07), versus $0.74 a year earlier. Full-year consensus is $3.26, growing to $3.65 the year after.
REVENUE · NEXT QUARTER
$799.1M
Range $791.0M – $805.4M · 6 analysts · +5% YoY
Revenue is expected to reach $799.1M (range $791.0M – $805.4M), +5.4% year-over-year. Full-year consensus is $3.0B, rising to $3.1B next year.
Top analysts covering Carter’s Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CRI.
#1
Ike Boruchow
Wells Fargo
Hold
$42.00+6.5% to target
Coverage
—
+ Follow
#2
Jay Sole
UBS
Hold
$41.00+4.0% to target
Coverage
—
+ Follow
#3
Paul Lejuez
Citigroup
Buy
$50.00+26.8% to target
Coverage
—
+ Follow
#4
PK
Paul Kearney
Barclays
Sell
$26.00-34.1% to target
Coverage
—
+ Follow
#5
CN
Christopher Nardone
B of A Securities
Sell
$26.00-34.1% to target
Coverage
—
+ Follow
CRI stock forecast FAQ
What is CRI's average 12-month price target?+
The 5 analysts with a live target average $37.60 for Carter’s Inc over the next 12 months, ranging from a $50.00 high to a $26.00 low.
Is CRI stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 6 analyst ratings, 1 are Buy or Strong Buy, 3 are Hold, and 2 are Sell or Strong Sell.
What are the highest and lowest price targets for CRI?+
The Street-high target is $50.00 (Citigroup), and the Street-low is $26.00 (Barclays). The average of all 5 active targets is $37.60.
How many Wall Street analysts cover CRI?+
6 analysts have an active rating on Carter’s Inc, and 5 firms carry a live 12-month price target.
Who is the most accurate analyst covering CRI?+
Among analysts who currently cover CRI, Ike Boruchow of Wells Fargo has the strongest overall Quantellect track record. Their current call is Hold with a $42.00 target.
What is Carter’s Inc's projected EPS for next quarter?+
The consensus estimate is $0.89 per share (range $0.70 – $1.07) across 6 analysts. Full-year EPS is projected at $3.26, rising to $3.65 the following year.
How much revenue is Carter’s Inc expected to report next quarter?+
Consensus revenue is $799.1M (range $791.0M – $805.4M). Full-year revenue is projected at $3.0B, growing to $3.1B next year.
Have analysts been upgrading or downgrading CRI lately?+
As of Jul, 1 of 6 firms rate CRI a Buy (3 Hold, 2 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CRI calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
